Methods Development in Natural Products Chemistry (R41/R42 Clinical Trial Not Allowed)
Funding Opportunity PA-18-682 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages Small Business Technology Transfer (STTR) grant applications from small business concerns (SBCs) to address highly innovative methods and technologies that significantly advance the field of natural products. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 26, 2018 Category: Research Source Type: funding
Countermeasures Against Chemical Threats (CounterACT) Research Centers of Excellence (U54 Clinical Trial Optional)
Funding Opportunity PAR-18-657 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages applications for Countermeasures Against Chemical Threats (CounterACT) Research Centers of Excellence (U54s). The mission of the CounterACT program is to foster and support research and development of new and improved therapeutics for chemical threats. Chemical threats are toxic chemicals that could be used in a terrorist attack or accidentally released from industrial production, storage or shipping. They include traditional chemical warfare agents, toxic industrial chemicals, pharmaceutica...
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 13, 2018 Category: Research Source Type: funding
NSF/CASIS Collaboration on Fluid Dynamics and Particulate and Multiphase Processes Research on the International Space Station to Benefit Life on Earth
Full Proposal Window: March 5, 2018 Program Guidelines: NSF 18-521The Division of Chemical, Bioengineering and Environmental Transport (CBET) in the Engineering Directorate of the National Science Foundation (NSF) is partnering with The Center for the Advancement of Science in Space (CASIS) to solicit research projects in the general field of fluid dynamics and particulate and multiphase processes that can utilize the International Space Station (ISS) National Lab to conduct research that will benefit life on Earth. U.S. entities including academic ...More at https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=505258&WT.mc_id...
Source: NSF Upcoming Due Dates - February 3, 2018 Category: Science Source Type: funding
Methods Development in Natural Products Chemistry (R43/R44 Clinical Trial Not Allowed)
Funding Opportunity PA-18-607 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research SBIR grant applications from small business concerns (SBCs) to address highly innovative methods and technologies that significantly advance the field of natural products. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 30, 2018 Category: Research Source Type: funding
Methods Development in Natural Products Chemistry (R41/R42 Clinical Trial Not Allowed)
Funding Opportunity PAR-18-608 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages Small Business Technology Transfer (STTR) grant applications from small business concerns (SBCs) to address highly innovative methods and technologies that significantly advance the field of natural products. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 30, 2018 Category: Research Source Type: funding
NSF/CASIS Collaboration on Tissue Engineering on the International Space Station to Benefit Life on Earth
Full Proposal Window: February 12, 2018 Program Guidelines: NSF 18-514The Division of Chemical, Bioengineering and Environmental Transport (CBET) in the Engineering Directorate of the National Science Foundation (NSF) is partnering with The Center for the Advancement of Science in Space (CASIS) to solicit research projects in the general field of tissue engineering that can utilize the International Space Station (ISS) National Lab to conduct research that will benefit life on Earth. U.S. entities including academic institutions, non-profit independent ...More at https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=505490&WT.m...
Source: NSF Upcoming Due Dates - January 13, 2018 Category: Science Source Type: funding
Dear Colleague Letter: Division of Chemistry's 2018 Supplemental Funding Requests for International Collaboration
Available Formats: HTML: https://www.nsf.gov/pubs/2018/nsf18037/nsf18037.jsp?WT.mc_id=USNSF_25&WT.mc_ev=clickPDF: https://www.nsf.gov/pubs/2018/nsf18037/nsf18037.pdf?WT.mc_id=USNSF_25&WT.mc_ev=clickDocument Number: nsf18037This is an NSF Program Announcements and Information item. (Source: NSF Program Announcements and Information)
Source: NSF Program Announcements and Information - January 5, 2018 Category: Science Source Type: funding
Two Years (or so) of “Open Mike”
Last year, as I reflected on finishing my first full year as NIH Deputy Director for Extramural Research, I noted five themes that reflected most of the content of this blog: applicant behavior, activity, and outcomes; peer review; basic science; biomedical research workforce and training; and scientific rigor, transparency, and research impact. Looking back on 2017, which was certainly a busy and active year, many of these themes continue to be at the forefront, though one in particular, the make-up and future of the biomedical research workforce, has been the center of much debate.
On May 2, we posted a blog on “Implem...
Source: NIH Extramural Nexus - December 29, 2017 Category: Research Authors: Mike Lauer Tags: blog Open Mike General Source Type: funding
Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44) - Clinical Trial Optional
Funding Opportunity PAR-18-541 from the NIH Guide for Grants and Contracts. The Blueprint Neurotherapeutics Network (BPN) encourages applications from small businesses seeking support to advance their small molecule drug discovery and development projects into the clinic. Participants in the BPN are responsible for conducting all studies that involve disease- or target-specific assays, models, and other research tools and receive funding for all activities to be conducted in their own laboratories. In addition, applicants will collaborate with NIH-funded consultants and can augment their project with NIH contract resear...
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 21, 2017 Category: Research Source Type: funding
Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3) - Clinical Trial Optional
Funding Opportunity PAR-18-546 from the NIH Guide for Grants and Contracts. The Blueprint Neurotherapeutics Network (BPN) invites applications from neuroscience investigators seeking support to advance their small molecule drug discovery and development projects into the clinic. Participants in the BPN are responsible for conducting all studies that involve disease- or target-specific assays, models, and other research tools and receive funding for all activities to be conducted in their own laboratories. In addition, applicants will collaborate with NIH-funded consultants and can augment their project with NIH contract...
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 21, 2017 Category: Research Source Type: funding
Development of Medications to Prevent and Treat Opioid Use Disorders and Overdose (UG3/UH3) (Clinical Trials Optional)
Funding Opportunity RFA-DA-19-002 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement is to support the discovery and development of medications to prevent and treat opioid use disorders (OUD) and overdose. The UG3/UH3 Phase Innovation Awards Cooperative Agreement involves 2 phases. The UG3 is to support a project with specific milestones to be accomplished by the end of the 2-year period. The UH3 is to provide funding for 3 years to a project that successfully completed the milestones set in the UG3. UG3 projects that have met their milestones will be administratively cons...
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 14, 2017 Category: Research Source Type: funding
NEI Audacious Goals Initiative: Translation-Enabling Models to Evaluate Survival and Integration of Regenerated Neurons in the Visual System (U24 Clinical Trials Not Allowed)
Funding Opportunity RFA-EY-17-003 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to stimulate development of translation-enabling models for evaluating survival and integration of regenerated photoreceptors (PRCs) and retinal ganglion cells (RGCs) in model systems that are closer to human visual anatomy, function and/or disease than current models. The development of these models, tools, devices, novel therapies and/or other resources is expected to provide a resource to vision researchers developing cell-replacement therapies for visual system diseases and disorders. This FOA seeks to develop ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 7, 2017 Category: Research Source Type: funding
Notice of Interest to Highlight NIDA High-Priority Workforce Development Needs in the Chemistry of Addiction
Notice NOT-DA-17-063 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 7, 2017 Category: Research Source Type: funding
Countermeasures Against Chemical Threats (CounterACT): Opportunities in Opioid Research
Notice NOT-NS-18-019 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 27, 2017 Category: Research Source Type: funding
Mentored Quantitative Research Development Award (Parent K25 - No Independent Clinical Trials)
Funding Opportunity PA-18-396 from the NIH Guide for Grants and Contracts. The purpose of the Mentored Quantitative Research Career Development Award (K25) is to attract to NIH-relevant research those investigators whose quantitative science and engineering research has thus far not been focused primarily on questions of health and disease. The K25 award will provide support and "protected time" for a period of supervised study and research for productive professionals with quantitative (e.g., mathematics, statistics, economics, computer science, imaging science, informatics, physics, chemistry) and engineering backgrou...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 22, 2017 Category: Research Source Type: funding
